๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP ยท Real-Time Price ยท USD
1.000
+0.010 (1.01%)
At close: Nov 18, 2026, 4:00 PM EST
1.030
+0.030 (3.00%)
Pre-market: Nov 19, 2026, 8:25 AM EST

Acurx Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-8.27-8.09-14.12-14.58-12.09-12.81
Net Income
-8.1-7.97-14.1-14.58-12.09-12.75
Earnings Per Share
-2.24-5.32-17.45-23.01-22.36-29.87
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.657.563.717.479.1112.96
Total Debt
------
Net Cash (Debt)
9.657.563.717.479.1112.96
Net Cash Growth
63.45%103.85%-50.41%-17.97%-29.69%316.83%
Net Cash Per Share
2.665.044.5911.8016.8530.36

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.79-6.79-10.38-9.8-7.54-5.01
Free Cash Flow
-6.79-6.79-10.38-9.8-7.54-5.01
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.